Patients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancer.

<h4>Background</h4>Metabolic syndrome and/or its components have been demonstrated to be risk factors for several cancers. They are also found to influence survival in breast, colon and prostate cancer, but the prognostic value of metabolic syndrome in gastric cancer has not been investi...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiao-li Wei, Miao-zhen Qiu, Huan-xin Lin, Ying Zhang, Jian-xin Liu, Hong-mei Yu, Wei-ping Liang, Ying Jin, Chao Ren, Ming-ming He, Wei-wei Chen, Hui-yan Luo, Zhi-qiang Wang, Dong-sheng Zhang, Feng-hua Wang, Yu-hong Li, Rui-hua Xu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089965&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849720474408321024
author Xiao-li Wei
Miao-zhen Qiu
Huan-xin Lin
Ying Zhang
Jian-xin Liu
Hong-mei Yu
Wei-ping Liang
Ying Jin
Chao Ren
Ming-ming He
Wei-wei Chen
Hui-yan Luo
Zhi-qiang Wang
Dong-sheng Zhang
Feng-hua Wang
Yu-hong Li
Rui-hua Xu
author_facet Xiao-li Wei
Miao-zhen Qiu
Huan-xin Lin
Ying Zhang
Jian-xin Liu
Hong-mei Yu
Wei-ping Liang
Ying Jin
Chao Ren
Ming-ming He
Wei-wei Chen
Hui-yan Luo
Zhi-qiang Wang
Dong-sheng Zhang
Feng-hua Wang
Yu-hong Li
Rui-hua Xu
author_sort Xiao-li Wei
collection DOAJ
description <h4>Background</h4>Metabolic syndrome and/or its components have been demonstrated to be risk factors for several cancers. They are also found to influence survival in breast, colon and prostate cancer, but the prognostic value of metabolic syndrome in gastric cancer has not been investigated.<h4>Methods</h4>Clinical data and pre-treatment information of metabolic syndrome of 587 patients diagnosed with early stage gastric cancer were retrospectively collected. The associations of metabolic syndrome and/or its components with clinical characteristics and overall survival in early stage gastric cancer were analyzed.<h4>Results</h4>Metabolic syndrome was identified to be associated with a higher tumor cell differentiation (P=0.036). Metabolic syndrome was also demonstrated to be a significant and independent predictor for better survival in patients aged >50 years old (P=0.009 in multivariate analysis) or patients with proximal gastric cancer (P=0.047 in multivariate analysis). No association was found between single metabolic syndrome component and overall survival in early stage gastric cancer. In addition, patients with hypertension might have a trend of better survival through a good control of blood pressure (P=0.052 in univariate analysis).<h4>Conclusions</h4>Metabolic syndrome was associated with a better tumor cell differentiation in patients with early stage gastric cancer. Moreover, metabolic syndrome was a significant and independent predictor for better survival in patients with old age or proximal tumors.
format Article
id doaj-art-5f3cc11bd6be4252bba2d31021a4ebce
institution DOAJ
issn 1932-6203
language English
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-5f3cc11bd6be4252bba2d31021a4ebce2025-08-20T03:11:55ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0193e8996510.1371/journal.pone.0089965Patients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancer.Xiao-li WeiMiao-zhen QiuHuan-xin LinYing ZhangJian-xin LiuHong-mei YuWei-ping LiangYing JinChao RenMing-ming HeWei-wei ChenHui-yan LuoZhi-qiang WangDong-sheng ZhangFeng-hua WangYu-hong LiRui-hua Xu<h4>Background</h4>Metabolic syndrome and/or its components have been demonstrated to be risk factors for several cancers. They are also found to influence survival in breast, colon and prostate cancer, but the prognostic value of metabolic syndrome in gastric cancer has not been investigated.<h4>Methods</h4>Clinical data and pre-treatment information of metabolic syndrome of 587 patients diagnosed with early stage gastric cancer were retrospectively collected. The associations of metabolic syndrome and/or its components with clinical characteristics and overall survival in early stage gastric cancer were analyzed.<h4>Results</h4>Metabolic syndrome was identified to be associated with a higher tumor cell differentiation (P=0.036). Metabolic syndrome was also demonstrated to be a significant and independent predictor for better survival in patients aged >50 years old (P=0.009 in multivariate analysis) or patients with proximal gastric cancer (P=0.047 in multivariate analysis). No association was found between single metabolic syndrome component and overall survival in early stage gastric cancer. In addition, patients with hypertension might have a trend of better survival through a good control of blood pressure (P=0.052 in univariate analysis).<h4>Conclusions</h4>Metabolic syndrome was associated with a better tumor cell differentiation in patients with early stage gastric cancer. Moreover, metabolic syndrome was a significant and independent predictor for better survival in patients with old age or proximal tumors.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089965&type=printable
spellingShingle Xiao-li Wei
Miao-zhen Qiu
Huan-xin Lin
Ying Zhang
Jian-xin Liu
Hong-mei Yu
Wei-ping Liang
Ying Jin
Chao Ren
Ming-ming He
Wei-wei Chen
Hui-yan Luo
Zhi-qiang Wang
Dong-sheng Zhang
Feng-hua Wang
Yu-hong Li
Rui-hua Xu
Patients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancer.
PLoS ONE
title Patients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancer.
title_full Patients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancer.
title_fullStr Patients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancer.
title_full_unstemmed Patients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancer.
title_short Patients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancer.
title_sort patients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancer
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089965&type=printable
work_keys_str_mv AT xiaoliwei patientswitholdageorproximaltumorsbenefitfrommetabolicsyndromeinearlystagegastriccancer
AT miaozhenqiu patientswitholdageorproximaltumorsbenefitfrommetabolicsyndromeinearlystagegastriccancer
AT huanxinlin patientswitholdageorproximaltumorsbenefitfrommetabolicsyndromeinearlystagegastriccancer
AT yingzhang patientswitholdageorproximaltumorsbenefitfrommetabolicsyndromeinearlystagegastriccancer
AT jianxinliu patientswitholdageorproximaltumorsbenefitfrommetabolicsyndromeinearlystagegastriccancer
AT hongmeiyu patientswitholdageorproximaltumorsbenefitfrommetabolicsyndromeinearlystagegastriccancer
AT weipingliang patientswitholdageorproximaltumorsbenefitfrommetabolicsyndromeinearlystagegastriccancer
AT yingjin patientswitholdageorproximaltumorsbenefitfrommetabolicsyndromeinearlystagegastriccancer
AT chaoren patientswitholdageorproximaltumorsbenefitfrommetabolicsyndromeinearlystagegastriccancer
AT mingminghe patientswitholdageorproximaltumorsbenefitfrommetabolicsyndromeinearlystagegastriccancer
AT weiweichen patientswitholdageorproximaltumorsbenefitfrommetabolicsyndromeinearlystagegastriccancer
AT huiyanluo patientswitholdageorproximaltumorsbenefitfrommetabolicsyndromeinearlystagegastriccancer
AT zhiqiangwang patientswitholdageorproximaltumorsbenefitfrommetabolicsyndromeinearlystagegastriccancer
AT dongshengzhang patientswitholdageorproximaltumorsbenefitfrommetabolicsyndromeinearlystagegastriccancer
AT fenghuawang patientswitholdageorproximaltumorsbenefitfrommetabolicsyndromeinearlystagegastriccancer
AT yuhongli patientswitholdageorproximaltumorsbenefitfrommetabolicsyndromeinearlystagegastriccancer
AT ruihuaxu patientswitholdageorproximaltumorsbenefitfrommetabolicsyndromeinearlystagegastriccancer